glucose, (beta-d)-isomer has been researched along with levamisole in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joyce, L; Lillehei, R; Mauer, H; Smith, J | 1 |
Bliznakov, EG | 1 |
Epishin, AV; Epishina, NA | 2 |
Deĭkalo, IN; Epishin, AV; Kuleshov, EV | 1 |
Veksler, IG | 1 |
Ferencík, M; Rovenský, J; Stefanovic, J | 1 |
Kenyon, AJ | 1 |
Davies, N; Jenkins, SA; Kynaston, H; Nott, DM; Taylor, BA; Yates, J | 1 |
9 other study(ies) available for glucose, (beta-d)-isomer and levamisole
Article | Year |
---|---|
Protection against superior mesenteric artery occlusion shock by soluble and nonsoluble reticuloendothelial stimulants.
Topics: Animals; Dogs; Enzymes; Female; Hemodynamics; Levamisole; Male; Mesenteric Arteries; Mesenteric Vascular Occlusion; Mononuclear Phagocyte System; Oxygen Consumption; Shock; Zymosan | 1978 |
Immunostimulation or immunodepression?
Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Dose-Response Relationship, Immunologic; Humans; Immunity; Immunosuppression Therapy; Immunotherapy; Leukemia; Levamisole; Linoleic Acids; Mice; Mice, Inbred Strains; Mycobacterium bovis; Ubiquinone; Zymosan | 1977 |
[Correction of immunologic reactivity in elderly patients with diffuse toxic goiter].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Aged; B-Lymphocytes; Drug Therapy, Combination; Female; Humans; Leukocyte Count; Levamisole; Lymphopenia; Male; Methimazole; Middle Aged; T-Lymphocytes; Thyrotoxicosis; Zymosan | 1990 |
[Use of immunoregulators in the complex preoperative preparation of patients with diffuse toxic goiter].
Topics: Adjuvants, Immunologic; Adult; Female; Graves Disease; Humans; Immune Tolerance; Immunity, Innate; Levamisole; Male; Middle Aged; Preoperative Care; Thyroidectomy; Zymosan | 1989 |
[Use of zymosan and levamisole in the complex treatment of patients with diffuse toxic goiter].
Topics: Adjuvants, Immunologic; Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Levamisole; Male; Middle Aged; Zymosan | 1986 |
[Comparative study of the effect of certain nonspecific stimulators on the body's immune response].
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; BCG Vaccine; Dextrans; Immunity, Cellular; Levamisole; Mice; Mice, Inbred BALB C; Prodigiosin; Rosette Formation; T-Lymphocytes; Tilorone; Zymosan | 1980 |
Lysosomal enzymes and metabolic activity of polymorphonuclear leukocytes from patients with systemic lupus erythematosus and from experimental animals after levamisole treatment.
Topics: Adult; Animals; Blood Proteins; Female; Humans; Levamisole; Lupus Erythematosus, Systemic; Lysosomes; Male; Middle Aged; Neutrophils; Rabbits; Superoxides; Time Factors; Zymosan | 1982 |
Delayed wound healing in mice associated with viral alteration of macrophages.
Topics: Animals; Glucans; Hepatitis, Viral, Animal; Herpes Simplex; Levamisole; Macrophages; Male; Mice; Murine hepatitis virus; Parainfluenza Virus 1, Human; Paramyxoviridae Infections; Rodent Diseases; Tensile Strength; Wound Healing; Zymosan | 1983 |
Reticuloendothelial stimulation: levamisole compared.
Topics: Animals; Chlormethiazole; Glucans; Injections, Intravenous; Kupffer Cells; Levamisole; Liver; Male; Mononuclear Phagocyte System; Octreotide; Organ Size; Random Allocation; Rats; Rats, Wistar; Spleen; Stimulation, Chemical; Technetium Tc 99m Sulfur Colloid; Zymosan | 1993 |